Tissue bank allografts have been the most widely used graft material for the last few decades. While we can achieve predictable results with good bone density, clinicians may still experience premature dehiscence of flaps, exposure and contamination of graft complexes, and incomplete resorption of graft material. With the introduction of new autologous growth factor protocols, many of these earlier potential complications can be mitigated or prevented. Fibrin-based autologous biologics can enhance the handling characteristics of particulate grafts, prevent salivary and bacterial contamination, speed the anastomosis of flap margins, and increase the percentage of vital bone in the regenerative site. This workshop will demonstrate the various ways we can add fibrin-based biologics to enhance the healing of graft complexes and achieve better clinical outcomes and give the clinician hands-on experience using these materials.